ASB Consultores’s Medtronic MDT Stock Holding History

ASB Consultores’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,018	Closed	-$321K	–	184
2024 Q4	$321K	Buy	4,018 +1,682	+72%	+$146K	0.13%	135
2024 Q3	$210K	Buy	+2,336	New	+$197K	0.08%	200
2024 Q2	–	Sell	-3,410	Closed	-$297K	–	256
2024 Q1	$297K	Buy	+3,410	New	+$291K	0.08%	220
2023 Q4	–	Sell	-3,151	Closed	-$247K	–	142
2023 Q3	$247K	Sell	3,151 -1,326	-30%	-$111K	0.1%	108
2023 Q2	$394K	Buy	4,477 +1,799	+67%	+$155K	0.19%	104
2023 Q1	$216K	Sell	2,678 -1,721	-39%	-$140K	0.09%	170
2022 Q4	$342K	Buy	4,399 +261	+6%	+$21.2K	0.14%	110
2022 Q3	$334K	Sell	4,138 -1,473	-26%	-$132K	0.16%	104
2022 Q2	$504K	Sell	5,611 -2,385	-30%	-$242K	0.22%	50
2022 Q1	$887K	Sell	7,996 -1,162	-13%	-$123K	0.37%	33
2021 Q4	$947K	Buy	+9,158	New	+$1.06M	0.47%	32

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ASB Consultores's MDT Position: Q1 2025 in Review

ASB Consultores sold out of Medtronic (MDT) in Q1 2025, closing a stake of 4,018 shares — an estimated $321K sold.

ASB Consultores first reported a position in MDT in Q4 2021 and held it in 11 quarters. The position peaked at $947K in Q4 2021. 2,177 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

ASB Consultores reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
ASB Consultores sold 4,018 Medtronic shares in Q1 2025, an estimated $321K.
ASB Consultores first reported a position in Medtronic in Q4 2021 and held it in 11 quarters.
ASB Consultores's Medtronic position peaked at $947K in Q4 2021.
2,177 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on ASB Consultores's 13F filing for Q1 2025, filed 13 May 2025.